RECRUITING

Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. It is the most expensive healthcare condition to treat in United States and has a mortality rate of nearly 30%. It is widely known that exaggerated inflammation and imbalance between sympathetic and parasympathetic arms of the autonomic nervous system (ANS) contribute to progression and adverse outcomes in sepsis. The role of unchecked inflammation and unregulated ANS as a potential treatment target is an important gap in our knowledge that should be explored. Cholinergic anti-inflammatory pathway (CAP) is an intricate network where the ANS senses inflammation by vagus nerve afferents and tries to regulate it by vagus nerve efferents to the reticuloendothelial system. The central hypothesis of this pilot clinical trial is that transcutaneous vagus nerve stimulation (TVNS) at tragus of the external ear can activate the CAP to suppress inflammation and improve autonomic imbalance as measured by inflammatory cytokine levels and heart rate variability (HRV) analysis. The investigators plan to randomize patients with septic shock into active and sham stimulation groups and study the effects of vagal stimulation on inflammatory cytokines, HRV and a clinical severity score of sepsis. Both groups will continue to receive the standard of care treatment for sepsis irrespective of group assignments. The investigators hypothesize that 4 hours of TVNS will suppress inflammatory markers and improve the balance between sympathetic and parasympathetic arms of ANS as measured by HRV, resulting in improved Sequential Organ Failure Assessment Score (SOFA). The preliminary data generated from this pilot study will lay the foundation for a larger clinical trial.

Official Title

Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

Quick Facts

Study Start:2019-10-10
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03992378

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. * Unilateral or bilateral vagotomy
  2. * History of myocardial infarction or stroke in the last 1 year
  3. * Recurrent vasovagal syncope
  4. * Sick sinus syndrome without pacemaker
  5. * Bifascicular heart block
  6. * 2nd or 3rd-degree heart block
  7. * Hypotension due to autonomic dysfunction
  8. * Pregnant women
  9. * Prisoners and patients with suicidal ideation

Contacts and Locations

Study Contact

Houssein Youness, MD
CONTACT
405-271-6173
Houssein-Youness@ouhsc.edu
Zain Ul Abideen Asad, MD
CONTACT
405-271-5963
Zain-Asad@ouhsc.edu

Principal Investigator

Houssein Youness, MD
PRINCIPAL_INVESTIGATOR
University of Oklahoma
Zain Ul Abideen Asad, MD
PRINCIPAL_INVESTIGATOR
University of Oklahoma

Study Locations (Sites)

University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104
United States

Collaborators and Investigators

Sponsor: University of Oklahoma

  • Houssein Youness, MD, PRINCIPAL_INVESTIGATOR, University of Oklahoma
  • Zain Ul Abideen Asad, MD, PRINCIPAL_INVESTIGATOR, University of Oklahoma

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-10-10
Study Completion Date2025-12

Study Record Updates

Study Start Date2019-10-10
Study Completion Date2025-12

Terms related to this study

Keywords Provided by Researchers

  • Sepsis

Additional Relevant MeSH Terms

  • Septic Shock